The EPS miss and GAAP loss are negative signals, but the divestiture and 20% software bookings growth provide some offset. Watch for Q2 2026 execution on services turnaround and whether the $0.35-$0.41 adjusted EPS guidance range proves achievable given the Q1 miss. The $40M buyback suggests management sees value, but declining fundamentals warrant caution.
Price Chart
Executive Summary
Certara reported Q1 2026 adjusted diluted EPS of $0.09, missing the $0.11 consensus by 15.1%, while revenue of $106.9M was slightly above the $106.1M estimate. The company swung to a GAAP net loss of $8.8M from a $4.7M profit a year ago, driven by higher operating expenses and a $7.4M contingent consideration charge. Guidance for full-year 2026 was updated to reflect the divestiture of the Regulatory and Medical Writing business, with revenue growth of 0%-4% excluding the divested unit and adjusted EPS of $0.35-$0.41.
Key Financial Metrics
Key Facts
- Adjusted diluted EPS of $0.09 missed consensus of $0.11 by 15.1%.
- Total revenue of $106.9M grew just 1% YoY, with services revenue declining 4%.
- GAAP net loss of $8.8M vs. net income of $4.7M in Q1 2025, a 285% decline.
- Adjusted EBITDA fell 9% YoY to $31.7M from $34.8M.
- Completed sale of Regulatory and Medical Writing business for $85M cash plus up to $50M in escrow and earn-out.
- Full-year 2026 guidance: revenue $395M-$405M (0%-4% growth ex-divestiture), adjusted EPS $0.35-$0.41.
- Software bookings grew 20% YoY, but services bookings fell 14%.
- Cash used to repurchase $40M in common stock during the quarter.
Financial Impact
EPS miss of ~$0.02 vs consensus; revenue slightly above consensus but growth decelerating; GAAP net loss swing of $13.5M YoY
Risk Factors
- Services revenue declining 4% YoY with execution challenges flagged by management
- GAAP net loss and negative operating income trend
- Guidance implies H2-weighted earnings, adding execution risk
- Contingent consideration and restructuring costs may continue to pressure GAAP results
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3291697 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 16, 2026 6w ago | Institutional Cluster | $8.00 $8.40 | ▲ +5.00% | ▲ +6.98% | $9.36 (+17.00%) |
Aug 4, 2026 8w ago | 8-K | $7.80 $8.10 | ▲ +3.85% | ▲ +5.08% | $9.36 (+20.00%) |
Jul 15, 2026 11w ago | Press Release | $7.28 $8.15 | ▲ +11.95% | ▲ +8.33% | $9.36 (+28.57%) |
Jun 11, 2026 16w ago | Institutional Cluster | $5.27 $6.79 | ▼ −28.84% | ▼ −26.95% | $9.36 (−77.61%) |
May 11, 2026 20w ago | 8-K | $5.13 $5.18 | ▼ −0.97% | ▼ −1.28% | $9.36 (−82.46%) |
May 11, 2026 20w ago | Press Release | $5.13 $5.18 | ▼ −0.97% | ▼ −1.28% | $9.36 (−82.46%) |
Apr 22, 2026 23w ago | 8-K / PRESS-RELEASE | $6.38 $4.59 | ▼ −28.06% | ▼ −31.22% | $9.36 (+46.71%) |
Apr 3, 2026 26w ago | DEFA14A | $5.46 $6.19 | ▲ +13.37% | ▲ +4.39% | $9.36 (+71.43%) |
Mar 30, 2026 26w ago | Court Ruling | $5.68 $6.14 | ▲ +8.10% | ▼ −4.50% | $9.36 (+64.79%) |
Mar 3, 2026 30w ago | Press Release | $7.24 $5.70 | ▼ −21.27% | ▼ −16.87% | $9.36 (+29.28%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access